• 33
  • 7
  • Favorite

IBM shares fell more than 2% in premarket trading

Tiger Newspress2022-01-11

IBM shares fell more than 2% in premarket trading.IBM is reportedly trying to sell its healthcare division, Watson Health for more than £700million.

The multinational technology corporation is hoping to receive more than £738million ($1billion) for the sale, the same amount asked for almost a year ago,Axios has reported.

Morgan Stanley led the process when they first explored a sale of the division in early 2021. At the time, WSJ reported that the unit was generating around $1billion in annual revenue but was unprofitable.

Sources claim the division continues to lose money, prompting renewed attempts to sell it in the opening days and weeks of 2022. IBM partnered with BofA Securities to find a buyer for Watson Health in late 2021.

One source states that bids were due in the last few days and IBM hope to select the winner by the close of January. A strategic buyer and several private equity firms are believed to be in the running.

This potential move by IBM follows Oracles £22.4billion acquisition of Cerner, an electronic health record (EHR) provider. Headquartered in Texas in the United States of America, Oracle defines itself as a “cloud technology company” and offers cloud application and platform services.

A report in the Financial Times said that a deal, in stark contrast to IBM, would help cement Oracle in the fast growing health IT sector as Cerner is one of the largest provider of hospital electronic medical systems to the US healthcare market and a leading supplier to the NHS.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment7

  • JeremyKok
    ·2022-01-12
    Was hoping to enter when the price reach $120. Do your own due diligence before you invest.
    Reply
    Report
  • Svkartik
    ·2022-01-11
    Considering entry at 125 if at all it gets there 
    Reply
    Report
  • Yani94
    ·2022-01-11
    Should hold buying the dip as I think it may dip even further
    Reply
    Report
  • jaswsf
    ·2022-01-11
    Good opp
    Reply
    Report
  • YIPKF
    ·2022-01-11
    Opportunity 
    Reply
    Report
  • miaoyin88
    ·2022-01-11
    like
    Reply
    Report
  • karen521818
    ·2022-01-11
    like
    Reply
    Report
 
 
 
 

Most Discussed

 
 
 
 
 

7x24

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email:uservice@ttm.financial